Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-03-31): -1.72%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
7.91%
NET PROFIT MARGIN AVG 3Y
-1.50%
NET PROFIT MARGIN AVG 5Y
-1.55%
NET PROFIT MARGIN AVG 10Y
-2.80%
NET PROFIT MARGIN AVG 15Y
-1.57%
NET PROFIT MARGIN AVG 20Y
-1.25%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Ridgetech, Inc.
Market Cap
$827005.00
Net Profit Margin
N/A
TTM Avg
7.91%
3Y Avg
-1.50%
5Y Avg
-1.55%
Market Cap
$827668.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-933.28%
5Y Avg
-622.19%
Market Cap
$829870.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-23.42%
Market Cap
$859025.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$913987.00
Net Profit Margin
-16.50%
TTM Avg
-15.59%
3Y Avg
-166.33%
5Y Avg
-1668.08%
Market Cap
$893920.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$715847.00
Net Profit Margin
N/A
TTM Avg
-384.13%
3Y Avg
-307.48%
5Y Avg
-251.31%
Market Cap
$701131.00
Net Profit Margin
6.30%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.04M
Net Profit Margin
-11314.24%
TTM Avg
-197362.53%
3Y Avg
-98681.26%
5Y Avg
-78945.01%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ridgetech, Inc. (RDGT) | $827005.00 | N/A | 7.91% | -1.50% | -1.55% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827668.00 | 0.00% | 0.00% | -933.28% | -622.19% |
| Decoy Therapeutics Inc. (DCOY)vs › | $829870.00 | 0.00% | 0.00% | 0.00% | -23.42% |
| Bone Biologics Corporation (BBLG)vs › | $859025.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $913987.00 | -16.50% | -15.59% | -166.33% | -1668.08% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $715847.00 | N/A | -384.13% | -307.48% | -251.31% |
| CDT Equity Inc. (CDT)vs › | $701131.00 | 6.30% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | -11314.24% | -197362.53% | -98681.26% | -78945.01% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -1.72% |
| 2025-09-30 | -0.10% |
| 2025-03-31 | 25.55% |
| 2024-09-30 | -3.20% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -4.36% |
| 2023-09-30 | -1.18% |
| 2023-03-31 | -27.00% |
| 2022-09-30 | -0.82% |
| 2022-03-31 | -3.41% |
| 2021-09-30 | -0.33% |
| 2021-03-31 | -0.39% |
| 2020-12-31 | -17.60% |
| 2020-09-30 | -4.84% |
| 2020-06-30 | -0.75% |
| 2020-03-31 | -9.84% |
| 2019-12-31 | 1.59% |
| 2019-09-30 | -4.32% |
| 2019-06-30 | -8.44% |
| 2019-03-31 | 13.53% |
| 2018-12-31 | -5.43% |
| 2018-09-30 | -5.79% |
| 2018-06-30 | -2.84% |
| 2018-03-31 | -53.22% |
| 2017-12-31 | -6.06% |
| 2017-09-30 | -4.98% |
| 2017-06-30 | -6.55% |
| 2017-03-31 | -25.46% |
| 2016-12-31 | -4.05% |
| 2016-09-30 | 0.49% |
| 2016-06-30 | 0.63% |
| 2016-03-31 | 3.92% |
| 2015-12-31 | -2.50% |
| 2015-09-30 | 0.67% |
| 2015-06-30 | 0.52% |
| 2015-03-31 | 5.38% |
| 2014-12-31 | 0.59% |
| 2014-09-30 | -0.20% |
| 2014-06-30 | -2.11% |
| 2014-03-31 | -94.78% |
| 2013-12-31 | -48.98% |
| 2013-09-30 | -3.24% |
| 2013-06-30 | -5.13% |
| 2013-03-31 | -68.49% |
| 2012-12-31 | -22.36% |
| 2012-09-30 | -5.73% |
| 2012-06-30 | 1.63% |
| 2012-03-31 | 6.75% |
| 2011-12-31 | 6.14% |
| 2011-09-30 | 7.35% |
| 2011-06-30 | 15.13% |
| 2011-03-31 | 11.48% |
| 2010-12-31 | 12.40% |
| 2010-09-30 | 10.38% |
| 2010-06-30 | 14.15% |
| 2010-03-31 | 23.74% |
| 2009-12-31 | 17.73% |
| 2009-09-30 | 13.90% |
| 2009-07-31 | 0.00% |
| 2009-04-30 | 0.00% |
| 2009-01-31 | 0.00% |
| 2008-10-31 | 0.00% |
| 2008-07-31 | 0.00% |
| 2008-04-30 | 0.00% |
| 2008-01-31 | 0.00% |
| 2007-10-31 | 0.00% |
| 2007-07-31 | 0.00% |
| 2007-01-31 | 0.00% |
